FDA.reportPublic FDA data

Glytone Acne Clearing Toner

Manufacturer
Pierre Fabre USA Inc.
Effective date
2023-01-02
Label type
HUMAN OTC DRUG LABEL
Version
11
Source
legacy-cache
Hydrated at
2026-08-01 21:33:31

Label at a glance#

ProductGlytone Acne Clearing Toner
Active ingredientSALICYLIC ACID
Label structure7 sections

Dosage and administration

After cleansing, apply toner to a cotton pad and gently apply over affected area one to three times daily, or as directed by a doctor. Do not rinse. Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two to three times daily if needed or as directed by a doctor. If bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 2%

Purpose

OTC - PURPOSE SECTION

Acne Treatment

Use

INDICATIONS & USAGE SECTION

For the treatment of acne.

  • Dries and clears acne blemishes and allows skin to heal.
  • Penetrates pores to eliminate most acne blemishes, blackheads, and whiteheads.
  • Helps prevent the development of new acne blemishes, blackheads, and whiteheads penetrates pores to control acne blemishes.

Warnings

WARNINGS SECTION

For external use only

SPL UNCLASSIFIED SECTION

Flammable: Keep away from fire or flame

SPL UNCLASSIFIED SECTION

When using this product

OTC - WHEN USING SECTION

  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
  • avoid contact with eyes. If eye contact occurs, rinse thoroughly with water.

Stop use and ask a doctor if rash occurs.

OTC - ASK DOCTOR SECTION


Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • After cleansing, apply toner to a cotton pad and gently apply over affected area one to three times daily, or as directed by a doctor.
  • Do not rinse.
  • Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two to three times daily if needed or as directed by a doctor.
  • If bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Acetone, Benzalkonium Chloride, Fragrance, Isopropyl Alcohol, Polysorbate 20, Red 40, Water, Yellow 5.

Principal Display Panel 240 mL Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

GLYTONE

Acne Clearing Toner

2.0

Salicylic Acid

240 mL 8.0 FL. OZ.

AcneTonerAcneToner

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
64760-706-012023-04-04C16284748780-1ba0f9c33-540b-a910-e053-dadaa90a0b85GLYTONE Acne Clearing Toner
64760-706-012023-01-30C16284748780-1ba0f9c33-540b-a910-e053-dadaa90a0b85GLYTONE Acne Clearing Toner
64760-706-012021-02-03C16284748780-1ba0f9c33-540b-a910-e053-dadaa90a0b85GLYTONE Acne Clearing Toner
64760-706-012021-01-29C16284748780-1ba0f9c33-540b-a910-e053-dadaa90a0b85GLYTONE Acne Clearing Toner

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
64760-70664760-706-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Name, UNII, Kind table
NameUNIIKind
ACETONE1364PS73AFIACT
BENZALKONIUM CHLORIDEF5UM2KM3W7IACT
ISOPROPYL ALCOHOLND2M416302IACT
POLYSORBATE 207T1F30V5YHIACT
FD&C RED NO. 40WZB9127XOAIACT
WATER059QF0KO0RIACT
FD&C YELLOW NO. 5I753WB2F1MIACT
SALICYLIC ACIDO414PZ4LPZACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
0f3b0ad6-b67c-bb55-e063-6294a90ac27f883a969c-ea2c-49ab-82d6-619a5b81ae122024-01-18WarningsExact identifier
spl set id: 883a969c-ea2c-49ab-82d6-619a5b81ae12

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.